Literature DB >> 23643861

Cloning and characterization of a novel human BRMS1 transcript variant in hepatocellular carcinoma cells.

Jun Wu1, Yingming Wang, Xiaojing Qiao, Hexige Saiyin, Shenan Zhao, Shouyi Qiao, Yanhua Wu.   

Abstract

Breast cancer metastasis suppressor 1 (BRMS1) is able to suppress tumor metastasis without affecting primary tumor growth in various cancers. Here, we report a novel transcript variant of human BRMS1, termed BRMS1.vh. BRMS1.vh is identical to the major BRMS1 variant (BRMS1.v1) except for missing base pairs 683-775, encoding a 215-amino acid protein lacking a functional nuclear localization sequence. Expression of BRMS1.vh in hepatocellular carcinoma (HCC) cells suppressed NF-κB signaling pathway, sensitized cells to apoptotic stimuli, leading to suppressed tumor growth. Taken together, our results suggest a potential role for BRMS1.vh in regulating cell apoptosis and tumor growth in HCC.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Breast cancer metastasis suppressor 1 (BRMS1); Hepatocellular carcinoma (HCC); Transcript variant

Mesh:

Substances:

Year:  2013        PMID: 23643861     DOI: 10.1016/j.canlet.2013.04.030

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

1.  Loss of BRMS1 promotes a mesenchymal phenotype through NF-κB-dependent regulation of Twist1.

Authors:  Yuan Liu; Marty W Mayo; Aizhen Xiao; Emily H Hall; Elianna B Amin; Kyuichi Kadota; Prasad S Adusumilli; David R Jones
Journal:  Mol Cell Biol       Date:  2014-11-03       Impact factor: 4.272

2.  Scinderin is a novel transcriptional target of BRMS1 involved in regulation of hepatocellular carcinoma cell apoptosis.

Authors:  Xiaojing Qiao; Yiren Zhou; Wenjuan Xie; Yi Wang; Yicheng Zhang; Tian Tian; Jianming Dou; Xi Yang; Suqin Shen; Jianwei Hu; Shouyi Qiao; Yanhua Wu
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

3.  MicroRNA-125a-5p inhibits invasion and metastasis of gastric cancer cells by targeting BRMS1 expression.

Authors:  Yi Cao; Shengxing Tan; Yi Tu; Guoyang Zhang; Yi Liu; Daojiang Li; Shan Xu; Zhibiao Le; Jianbo Xiong; Wenyu Zou; Peitao Gong; Zhengrong Li; Zhigang Jie
Journal:  Oncol Lett       Date:  2018-02-07       Impact factor: 2.967

4.  Down-regulation of BRMS1 by DNA hypermethylation and its association with metastatic progression in triple-negative breast cancer.

Authors:  Bin Kong; Zhi-Dong Lv; Yu Wang; Li-Ying Jin; Lei Ding; Zhao-Chuan Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  Breast cancer metastasis suppressor 1 modulates SIRT1-dependent p53 deacetylation through interacting with DBC1.

Authors:  Xueni Liu; Elphire Ehmed; Boyao Li; Jianming Dou; Xiaojing Qiao; Wenyong Jiang; Xi Yang; Shouyi Qiao; Yanhua Wu
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

Review 6.  BRMS1: a multifunctional signaling molecule in metastasis.

Authors:  Rosalyn C Zimmermann; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

7.  BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients.

Authors:  Yu Wu; Huijuan Wang; Jingtai Zhi; Linfei Hu; Xiukun Hou; Xianhui Ruan; Xiangqian Zheng; Hui Liu; Ming Gao
Journal:  Onco Targets Ther       Date:  2019-08-28       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.